Zai Lab and Pfizer Inc. are teaming up in China to fight the deadly carbapenem-resistant Acinetobacter baumannii (CRAB) infection with novel antibacterial drug Xacduro (sulbactam-durlobactam). Through ...

Yet, carbapenem-resistant Acinetobacter baumannii (CRAB) is a nightmare for hospitals worldwide, as it kills roughly half of all patients who acquire it. Identified as a top-priority pathogen by ...

Scientists have made a groundbreaking discovery of a new class of antibiotic called Zosurabalpin, demonstrating its effectiveness against Carbapenem-resistant Acinetobacter baumannii (Crab), a ...

It is published in the journal Nature. US researchers focused on finding a new way to treat infections caused by the carbapenem-resistant Acinetobacter baumannii (Crab) bacterium. The organism ...

Researchers discovered the ST164 variant of Carbapenem-resistant Acinetobacter baumannii (CRAB) in a Chinese intensive care unit (ICU) as part of their study into how bundled infection prevention and ...

Xacduro is the only antimicrobial agent specifically developed for the treatment of carbapenem-resistant Acinetobacter baumannii (CRAB). It has been approved in the United States and in mainland China ...

XACDURO ® is the only antimicrobial agent specifically developed for the treatment of carbapenem-resistant Acinetobacter baumannii (CRAB) 1. It has been approved in the United States and in ...